Recombinant allergens for diagnosis and therapy of allergic disease

Journal of Allergy and Clinical Immunology

Volumn 106, Issue 3, 2000, Pages 409-418

  Chapman, Martin D ^a   Smith, Alisa M ^a   Vailes, Lisa D ^a   Arruda, L Karla ^a   Dhanaraj, Venugopal ^a   Pomés, Anna ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Allergen immunotherapy; Allergy diagnostics; Allergy therapeutics; Allergy vaccines; Animal allergens; Asthma; Mites; Recombinant allergens

Indexed keywords

ALLERGEN; ENZYME; ENZYME INHIBITOR; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; IMMUNOLOGICAL ADJUVANT; LIPOCALIN; PEPTIDE; POLLEN ANTIGEN; RECOMBINANT PROTEIN; STRUCTURAL PROTEIN; VACCINE;

ALLERGIC DISEASE; ANTIBODY RESPONSE; ANTIGEN BINDING; ASTHMA; GENE EXPRESSION SYSTEM; GENETIC ENGINEERING; IMMUNOTHERAPY; PRIORITY JOURNAL; REVIEW; SKIN TEST;

EID: 0034515409     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2000.109832     Document Type: Article

References (91)

1. Asthma, and Immunology. The use of standardized allergen extracts [position statement]
2. Allergen immunotherapy: Therapeutic vaccines for allergic diseases [WHO position paper]
3. False-positive skin prick test responses to commercially available dog dander extracts caused by contamination with house dust mite (Dermatophagoides pteronyssinus) allergens
4. Role of proteases on the stability of allergenic extracts
5. Studies of allergen extract stability: The effects of dilution and mixing
6. Basic and practical aspects of recombinant allergens
7. Recombinant mite allergens: New technologies for the management of patients with asthma
8. Towards defining the full spectrum of house dust mite allergens
9. The recombinant allergen-based concept of component resolved diagnostics and immunotherapy (CRD and CRIT)
10. X-ray and NMR structure of Bet v I, the origin of birch pollen allergy
11. Comparative modelling of major house dust mite allergen Der p I: Structure validation using an extended environmental amino acid propensity table
12. Tertiary structure of the major house dust mite allergen Der p 2: Sequential and structural homologies
13. Comparative modeling of Bla g 2, a cockroach allergen and inactive aspartic proteinase
14. Probing the molecular basis of allergy: Three-dimensional structure of the bovine lipocalin allergen Bos d 2
15. Crystal structure of the allergen Equ c 1: A dimeric lipocalin with restricted IgE-reactive epitopes
16. Structure of the major peanut allergen, Ara h 1, may protect IgE binding epitopes from degradation
17. GenBank
18. Indoor allergens and asthma: Report of the third international workshop
19. T cell responses to allergens: Epitope-specificity and clinical relevance
20. The biochemistry of common aeroallergens
21. Functional properties of cloned allergens from dust mite, cockroach and cat - Are they relevant to allergenicity?
22. Allergy to lipocalins: A consequence of misguided T-cell recognition of self and nonself?
23. Allergy to mammalian proteins: At the borderline between foreign and self?
24. Cloning of cockroach allergen, Bla g 4, identifies ligand binding proteins (or calycins) as a cause of IgE antibody responses
25. The lipocalin protein family: Structure and function
26. Pheromone binding to two rodent urinary proteins revealed by X-ray crystallography
27. β-Lactoglobulin binds palmitate within its central cavity
28. The major dog allergens, Can f 1 and Can f 2, are salivary lipocalin proteins: Cloning and immunological characterization of the recombinant forms
29. The salivary lipocalin von Ebner's gland protein is a cysteine proteinase inhibitor
30. Identification of a novel cat allergen - Cystatin
31. Identification of tropomyosin as the major shrimp allergen and characterization of its IgE-binding epitopes
32. Identification of the major brown shrimp (Penaeus aztecus) allergen as the muscle protein tropomyosin
33. Cloning, expression, and primary structure of Metapenaeus ensis tropomyosin, the major heat-stable shrimp allergen
34. Immunochemical characterization of recombinant and native tropomyosins as a new allergen from the house dust mite, Dermatophagoides farinae
35. Sequencing and high level expression in Escherichia coli of the tropomyosin allergen (Der p 10) from Dermatophagoides pteronyssinus
36. Cockroach allergens and asthma in Brazil: Identification of tropomyosin as a major allergen with potential cross-reactivity with mite and shrimp allergens
37. Identification of a cross-reactive allergen (presumably tropomyosin) in shrimp, mite and insects
38. IgE reactivity against a cross-reactive allergen in crustacea and mollusca: Evidence for tropomyosin as the common allergen
39. Asthma after consumption of snails in house dust mite allergic patients: A case of IgE cross-reactivity
40. A major house dust mite allergen disrupts the IgE network by selectively cleaving CD23: Innate immunity by anti-proteases
41. Der p I, a major allergen of the house dust mite, proteolytically cleaves the low-affinity receptor for human IgE (CD23)
42. Proteolytic cleavage of CD25, the α sub-unit of the human T cell interleukin 2 receptor, by Der p 1, a major mite allergen with cysteine protease activity
43. A mite subversive: Cleavage of CD23 and CD25 by Der p 1 enhances allergenicity
44. On the potential significance of the enzymatic activity of mite allergens to immunogenicity: Clues to structure and function revealed by molecular characterization
45. Dust mite proteolytic allergens induce cytokine release from cultured airway epithelium
46. Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions
47. The proteolytic activity of Der p 1 selectively enhances IgE synthesis: A link between allergenicity and cysteine protease activity
48. Molecular cloning of a major cockroach allergen, Bla g 2
49. X-ray analyses of aspartic proteinases, II: Three-dimensional structure of the hexagonal crystal form of porcine pepsin at 2.3 Å ± resolution
50. Novel allergen structures with tandem amino acid repeats derived from German and American cockroach
51. Molecular cloning of Per a 1 and definition of the cross-reactive group 1 cockroach allergens
52. Sequence polymorphisms and antibody binding to the group 2 dust mite allergens
53. IgE antibodies to recombinant forms of Fel d 1: Dichotomy between fluid phase and solid-phase binding studies
54. Enhanced immunoreactivity and preferential heterodimer formation of reassociated Fel d 1 recombinant chains
55. Purified natural and recombinant Fel d 1 and cat albumin in in vitro diagnostics for cat allergy
56. Fully immunoreactive recombinant cat allergen, Fel d 1, expressed in baculovirus
57. Cloning and expression in yeast Pichia pastoris of biologically active form of Cyn d 1, the major allergen of Bermuda grass pollen
58. Isolation and expression of a cDNA clone encoding an Alternaria alternata Alt a 1 subunit
59. Expression of a lipocalin in Pichia pastoris: Secretion, purification, and binding activity of a recombinant mouse major urinary protein
60. High level expression of cockroach allergen, Bla g 4, in Pichia pastoris
61. Isolation of the Pichia pastoris glyceraldehyde-3-phosphate gene and regulation and use of its promoter
62. Production of recombinant Der f I with the native IgE-binding activity using a baculovirus expression system
63. Biochemical and immunological characterization of a recombinant precursor form of the house dust mite allergen Der p 1 produced by Drosophila cells
64. A recombinant house dust mite (HDM) allergen, rDer f l, with IgE binding activity comparable to the native allergen
65. Blomia tropicalis and cockroaches as important allergens
66. Recombinant allergens for diagnosis of mite allergy in children with asthma and/or rhinitis: Comparison with commercial extracts
67. Modification of a major peanut allergen leads to loss of IgE binding
68. Standardization of allergen extracts - A mission impossible?
69. Regulation of the human immune response to ragweed pollen by immunotherapy: A controlled trial comparing the effect of immunosuppressive peptic fragments of short ragweed with standard treatment
70. Reduction in IgE binding to allergen variants generated by site-directed mutagenesis: Contribution of disulfide bonds to the antigenic structure of the major house dust mite allergen, Der p 2
71. Engineering of the major house dust mite allergen Der f 2 for allergen-specific immunotherapy
72. "Allergen engineering": Variants of the timothy grass pollen allergen Phl p 5b with reduced IgE-binding capacity but conserved T cell reactivity
73. Peanut-induced anaphylactic reactions
74. Molecular cloning and epitope analysis of the peanut allergen Ara h 3
75. Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: Results obtained with a mix of two recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the birch pollen season
76. Hypoallergenic isoform variants of allergens - A new concept for specific immunotherapy
77. Immunostimulatory DNA and applications to allergic disease
78. Interleukin-12 as a target for modulation of the inflammatory response in asthma
79. Vaccination with heat-killed Listeria as adjuvant reverses established allergen-induced airway hyperreactivity and inflammation: Role of CD8+ T cells and IL-18
80. Vaccination with ovalbumin-IL-18 fusion DNA protects against airway hyperreactivity in a murine model: Dependence on interferon-gamma and CD8 cells
81. The potent IgG4-inducing antigen in banana is a mannose binding lectin, BanLec-I
82. Allergen-specific immunotherapy: New strategies using recombinant allergens
83. Treatment of cat allergy with T-cell reactive peptides
84. Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions
85. Inhibition of allergic inflammation with T cell epitopes
86. Use of non-stimulatory peptides: A new strategy for immunotherapy?
87. Strategic targets for primary prevention of allergic disease in childhood
88. Immunoprophylaxix of atopy: Light at the end of the tunnel?
89. Cord blood proliferative responses to inhaled allergens: Is there a phenomenon?
90. Mite, cat and cockroach exposure, allergen sensitisation and asthma in children: A case control study of three schools
91. Exposure to high concentrations of cat allergen at home is associated with increased IgG and IgG4 ab but not IgE ab to Fel d 1: IgG4 as a marker for a modified Th2 response